Skip to main content
. 2023 Jun 9;14:1194123. doi: 10.3389/fimmu.2023.1194123

Table 3.

Multivariate Cox analysis of PFS or OS by clinical parameters, PD-L1 status and CXCL12 level.

Factor PFS OS
p value HR (95% CI) p value HR (95% CI)
PD_L1 TPS
≥1% vs. <1%
0.003 0.48 (0.29-0.78) 0.247 0.68 (0.36-1.30)
Liver Metastasis
Yes vs. No
0.025 2.17 (1.10-4.29) 0.043 2.24 (1.03-4.90)
irAEs
Yes vs. No
0.001 0.39 (0.22-0.69) 0.046 0.41 (0.17-0.98)
CXCL12
Top 1/3 vs. Bottom 2/3
4e-04 3.01 (1.63-5.55) 0.001 4.63 (1.81-11.80)
MIF
Top 1/3 vs. Bottom 2/3
0.915 1.03 (0.56-1.90) 0.079 0.42 (0.16-1.10)

irAE, immune-related adverse events; TPS, tumor proportion score; CI, confidence interval; HR, hazard ratio; the bold values, p < 0.